Review
Version 1
Preserved in Portico This version is not peer-reviewed
Advances of Protein Palmitoylation in Tumor Cell Deaths
Version 1
: Received: 9 November 2023 / Approved: 9 November 2023 / Online: 9 November 2023 (07:43:38 CET)
A peer-reviewed article of this Preprint also exists.
Lin, X.; Shi, Y.; Zhan, Y.; Xing, Y.; Li, Y.; Zhou, Z.; Chen, G. Advances of Protein Palmitoylation in Tumor Cell Deaths. Cancers 2023, 15, 5503. Lin, X.; Shi, Y.; Zhan, Y.; Xing, Y.; Li, Y.; Zhou, Z.; Chen, G. Advances of Protein Palmitoylation in Tumor Cell Deaths. Cancers 2023, 15, 5503.
Abstract
In this comprehensive survey, we delve into the multifaceted role of palmitoylation across vari-ous cell death modalities in the oncological context. From its intricate correlations with tumor-igenesis, steered by the DHHC family, to the counter-process of depalmitoylation mediated by enzymes like PPT1. Innovations in detection methodologies have paralleled our growing under-standing, transitioning from rudimentary techniques to sophisticated modern methods. Central to our discourse are agents like GNS561 and DC661, promising heralds in palmitoylation-targeted cancer therapy. Collectively, this review accentuates palmitoylation's transformative potential in oncology, foreshadowing groundbreaking therapeutic strategies and deepening our molecular comprehension of cancer dynamics.
Keywords
protein palmitoylation; apoptosis; autophagy; ferroptosis; pyroptosis
Subject
Biology and Life Sciences, Cell and Developmental Biology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment